Valeant Offers New Psoriasis Drug for $3,500/Month

Valeant Pharma priced its recently approved psoriasis treatment at $3,500 per month, which it says is lowest priced injectable biologic psoriasis treatment on the market.

April 21, 2017

Canada's Valeant Pharmaceuticals International priced its soon-to-be-released plaque psoriasis treatment at $3,500 per month, ahead of its U.S. launch coming in the second half of 2017.

Valeant says Siliq is the lowest priced injectable biologic psoriasis treatment currently on the market.

The treatment blocks a cell receptor known as interleukin-17, and it will compete with a many existing IL-17 inhibitors including Cosentyx from Novartis AG and Taltz from Eli Lilly & Co, according to a Reuters article.

Read the full story